NEW CANAAN, CT, April 26, 2004—As “Vaccination Week” in the Americas unfolds this week, the Sabin Vaccine Institute joins with the international sponsors in declaring the need for a reduction in immunization inequities among children and women who have never been vaccinated. The week of community awareness activities and national immunization campaigns opened April 24 with a regional launch in the small village of Fond Parisien, Haiti, where local children received life-saving vaccinations.
Leading experts are available to comment on the science and safety of vaccines, and parents are available to discuss what can happen when parents choose not to immunize their children.
NEW CANAAN, CT, April 7, 2004—The regulation of cancer vaccines by the U.S. Food and Drug Administration (FDA) and European Union offers both opportunities and potential pitfalls for industry and research, according to speakers at last week’s meeting of the Cancer Vaccine Consortium (CVC), “Federal Regulation and Cancer Vaccines.” As part of the meeting, the CVC launched two new working groups to address regulatory issues and engage the FDA in policy discussions.
NEW CANAAN, CT— The Cancer Vaccine Consortium (www.sabin.org/cv_consortium.htm) will hold its third semi-annual meeting April 1-2, 2004 in Orlando, Florida, to explore federal regulation of cancer vacci
NEW CANAAN, CT—The Board of Trustees of the Albert B. Sabin Vaccine Institute announced the election of their newest board member, Walter Orenstein, MD. Recently recruited as Professor of Medicine and Pediatrics at Emory University School of Medicine, Dr. Orenstein’s posts at Emory will include director of the Program for Vaccine Policy and Development and associate director of the Vaccine Center. Dr.